rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Clinical trial NCT04943848 · RECRUITING

Trial details

NCT number: NCT04943848
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma, H3 K27M-Mutant

Start date: 2022-01-10
Primary completion: 2026-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.